EVGN: Evogene Ltd. Market Cap to Revenue Ratio

Brandmark of Evogene, Ltd. (EVGN)

Evogene Ltd. (EVGN) utilizes Big Data and the CPB system to accelerate the synthesis of pharmaceuticals and agrochemicals. The high productivity of its software core currently drives the development of the R&D pipeline in computational biology. Growth is supported by partner payments and the search for new therapeutic targets. The P/S multiple demonstrates the correlation between the share price and revenue, with the value maintained at 3.80.

Evogene Ltd. (EVGN): P/S Multiple from 07/04/2022 to 11/13/2026

Analytical breakdowns for Evogene Ltd. (EVGN)

- stock quotes and analyst forecast:
Price evogene.com|EVGN - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Evogene, Ltd.|EVGN - Real Price to Acquire Entire Company
- business book valuation details:
Net Assets per Share Evogene|EVGN - Book Capitalization|Market-to-Book Ratio evogene.com|EVGN - Cumulative Company Assets
- business debt structure and liquidity details:
Debt to Equity Evogene Ltd.|EVGN - Long-Term Debt to Capital|Short-Term Indebtedness to Equity evogene.com|EVGN - Company Debts|Debt to Book Value Ratio Evogene, Ltd.|EVGN - Company Long-Term Debts|Company Short-Term Debts Evogene|Interim Coverage Ratio evogene.com
- net income and valuation ratios data:
EVGN - Net Profit|Expected Net Profit Evogene Ltd.|EVGN - Price to Earnings Ratio|Future Price to Earnings evogene.com|EVGN - Price/Earnings to Growth Ratio|Company Value to EBITDA Evogene, Ltd.|EVGN - Operating profit EBITDA|Net earnings per share for the trailing year Evogene|EVGN - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months evogene.com|EVGN - Earnings per share growth in current year|Projected earnings per share growth rate for next year Evogene Ltd.
- issuer revenue and sales details:
EVGN - Revenue and Sales Volume|Company Expected Sales Volume evogene.com|EVGN - Market Cap to Revenue|Forward Price to Sales Evogene, Ltd.
Fundamental company analysis:Evogene Ltd (EVGN)
Product sample of evogene.com

Evogene Ltd. (EVGN) automates plant breeding via AI platforms, transforming biological design into a digital asset. The P/S ratio compares current market capitalization to annual sales volume, measuring the cost of every dollar of revenue. This calculation helps investors determine the extent to which the business is overvalued relative to its ability to generate income. Price-to-sales valuation trends allow for the timely identification of market imbalances and the risk of asset stagnation.

Competing companies

Market Cap to Sales Volume NVDA|P/S Multiple CRWV (CoreWeave)|NBIS: Market Cap to Revenue Ratio|SOUN: Market Cap to Revenue|Price-to-Revenue Coefficient Zeta Global Holdings ZETA|PGY: P/S Multiple|Price to Sales C3.ai Inc (AI)|Market Cap to Revenue RXRX|Price-to-Revenue Ratio RZLV|P/S Multiple SUPX|Ginkgo Bioworks Corp. (DNA) - Price-to-Revenue Multiple|Price-to-Revenue Ratio Cerence Inc. CRNC|PDYN: Market Cap to Revenue Ratio|Veritone Corp - P/S Multiple|MIMI - P/S Multiple|MLGO: P/S Multiple|HPAI - Price-to-Revenue Coefficient|LPSN (LivePerson, Inc.) - P/S Multiple|Price to Sales QuickLogic Corp. QUIK|Market Cap to Revenue SST (System1, Inc.)|Price-to-Revenue Ratio DVLT (Datavault AI Inc.)|Price-to-Revenue Ratio Ruanyun Edai Tech RYET|Wetour (WETO) - Price to Sales|Micropolis Holding - P/S Multiple|Price-to-Revenue Multiple Cyngn Inc. (CYN)|YYAI: P/S Multiple|Price to Sales MicroCloud Hologram Inc. (HOLO)|Price-to-Revenue Ratio MultiSensor AI Holdings|Market Cap to Revenue Ratio EVAX (Evaxion Biotech AS)|P/S Multiple AIXI|CXAI - Price to Sales|Brand Engagement Network Inc. - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio GXAI|IFBD - Price-to-Revenue Ratio|TAOP: Price-to-Revenue Ratio|VSAI (verses.ai) - Market Cap to Revenue|EXAI: Market Cap to Sales Volume|FOXO (FOXO Technologies) - P/S Multiple|Market Cap to Revenue Ratio VHAI (Vocodia)|Market Cap to Revenue ZPTA (Zapata Computing Holdings)